Evidence map›Paper›PMID 26059557›Full record

ArticleScientific reports2015

Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function.

Ming-Lu Liang, Xing-Wen Da, Ao-Di He, Guang-Qiang Yao, Wen Xie, Gang Liu, Ji-Zhou Xiang, Zhang-Yin Ming

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Post-operative epidural haematoma as complication of overconsumption of dried fruit in lumbar spinal surgery: a case report and review of the literature.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ming-Lu Liang1] Department of Pharmacology, School of Basic Medicine, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China [2] The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China.
Xing-Wen Da1] Department of Pharmacology, School of Basic Medicine, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China [2] The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China.
Ao-Di He1] Department of Pharmacology, School of Basic Medicine, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China [2] The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China.
Guang-Qiang Yao1] Department of Pharmacology, School of Basic Medicine, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China [2] The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China.
Wen Xie1] Department of Pharmacology, School of Basic Medicine, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China [2] The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China.
Gang Liu1] Department of Pharmacology, School of Basic Medicine, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China [2] The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China.
Ji-Zhou Xiang1] Department of Pharmacology, School of Basic Medicine, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China [2] The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China [3] The Institute of Brain Research, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China.
Zhang-Yin Ming1] Department of Pharmacology, School of Basic Medicine, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China [2] The Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China [3] The Institute of Brain Research, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China.
Huazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavonoids exert both anti-oxidant and anti-platelet activities in vitro and in vivo. Pentamethylquercetin (PMQ), a polymethoxylated flavone derivative, has been screened for anti-carcinogenic and cardioprotective effects. However, it is unclear whether PMQ has anti-thrombotic effects. In the present study, PMQ (20 mg/kg) significantly inhibited thrombus formation in the collagen- epinephrine- induced acute pulmonary thrombosis mouse model and the ferric chloride-induced carotid injury model. To explore the mechanism, we evaluated the effects of PMQ on platelet function. We found that PMQ inhibited platelet aggregation and granule secretion induced by low dose agonists, including ADP, collagen, thrombin and U46619. Biochemical analysis revealed that PMQ inhibited collagen-, thrombin- and U46619-induced activation of Syk, PLCγ2, Akt, GSK3β and Erk1/2. Therefore, we provide the first report to show that PMQ possesses anti-thrombotic activity in vivo and inhibited platelet function in vitro, suggesting that PMQ may represent a potential therapeutic candidate for the prevention or treatment of thrombotic disorders.

Indexed as

15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidAnimalsBlood PlateletsMiceMice, Inbred C57BLPlatelet Aggregation InhibitorsQuercetinThrombinThrombosis15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid3,3',4',5,7-pentamethylquercetinPlatelet Aggregation InhibitorsQuercetinThrombin

Identifiers

PMID26059557
PMCPMC4461919
OpenAlexW600201617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.